Zimmer, Alexandra S <br/><br/>
Temozolomide in secondary prevention of HER2-positive breast cancer brain metastases.  [electronic resource] 

 -  Future oncology (London, England)  May 2020 
 - 899-909 p.  digital 
<br/><br/> Publication Type: Clinical Trial Protocol; Journal Article 
<br/><br/><label>ISSN: </label>1744-8301 
<br/><br/><label>Standard No.: </label>10.2217/fon-2020-0094  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Female<br/>Humans<br/>Antineoplastic Agents, Alkylating--pharmacology<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Biomarkers, Tumor<br/>Brain Neoplasms--secondary<br/>Breast Neoplasms--metabolism<br/>Drug Evaluation, Preclinical<br/>Research Design<br/>Telomerase--metabolism<br/>Temozolomide--pharmacology<br/>Clinical Trials, Phase I as Topic<br/>Clinical Trials, Phase II as Topic